Ticker: ADMA

ADMA Biologics, Inc. (NASDAQ: ADMA) has released its quarterly financial report for the period ending June 30, 2025. Here are the key points from the recent earnings statements and company developments. Revenue: Revenues reached $121.98 million for the three months ended June 30, 2025, reflectin...